Article Text


PWE-085 CT Enterography Remains a Valuable Tool for the Assessment of Crohn’s Disease
  1. K L White1,
  2. C A Boyd1,
  3. M Sapundzieski2,
  4. J K Limdi1
  1. 1Gastroenterology
  2. 2Radiology, Pennine Acute Hospitals Trust, Manchester, UK


Introduction Advances in the immunopathogenesis of inflammatory bowel disease (IBD) coupled with bolder definitions of disease control have led to increasing reliance on imaging to characterise inflammation beyond the reach of the endoscope. Clinical activity indices underestimate biologic activity and cannot detect transmural disease. We aimed to assess the role of CT enterography (CTE) in assessing Crohn’s disease (CD).

Methods A retrospective review of 406 consecutive CTE studies was performed between January 2009 and December 2012 at our institution. Clinical data including demographics, disease characteristics and therapy were obtained from electronic patient record review. Inflammatory markers, radiological investigations and ileocolonoscopy when performed within 90 days of CTE were recorded. CTE reports were recorded using accepted activity criteria- small bowel dilatation, stenosis, wall thickening, enhancement, mucosal irregularity, mesenteric inflammation, hypervascularity, lymph node enlargement, abscesses, fistulation and extraintestinal features.

Results Of 175 patients with IBD at time of CTE, 154 had CD. Ninety-four of 154 patients were female, mean age 52 (range 16–87) and median term of follow up of 5 years (range 0–35).

Abnormalities were noted in 100 scans; 56 had active non-stricturing, 42 active stricturing and 2 fibrostenotic disease. Within active groups, there were 10 fistulae and 3 abscesses in 11 patients. Ileo-colonoscopy was performed in 42 patients with 27 showing active inflammation and raised CRP in 38/96. Treatment was increased in 52% of the active non-stricturing group, 6/29 to azathioprine, 4/29 to biologics, 4/29 to methotrexate, 7/29 to steroids, 5/29 to surgery with no change in the remaining 48%, of whom 8/12 had inactive disease at ileo-colonoscopy and 16/24 normal CRP.

In 57% of active stricturing patient treatment was increased in 1 to azathioprine, 11 to biologics, 5 to surgery. Twelve of 26 patients in this group had an elevated CRP and 10/13 had active colitis at ileo-colonoscopy.

Of 53 normal CTE, treatment was escalated in 3 to methotrexate or azathioprine with colitis at colonoscopy and unchanged in 92%.

Conclusion Concerns regarding potential cumulative effects of ionising radiation are valid but likely to be offset by changing technology and reduction in average doses of radiation.

CTE has a role in well-selected patients with CD (e.g. age > 50, very sick patients) identifying active disease and influencing meaningful therapeutic decisions.

Disclosure of Interest None Declared.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.